Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3)
|
Author:
|
Jung, Susanne; Schlenk, Richard F.; Hackenbruch, Christopher; Pinzon, Sandra S. L. Roldan; Bitzer, Michael; Pfluegler, Martin; Walz, Juliane S.; Jung, Gundram; Heitmann, Jonas S.; Salih, Helmut R.
|
|
Tübinger Autor(en):
|
|
|
Published in:
|
Frontiers in Oncology
(2024), Bd.
14,
Article 1351901
|
|
Verlagsangabe:
|
Lausanne : Frontiers Media Sa
|
|
Language:
|
English
|
|
Full text:
|
http://dx.doi.org/10.3389/fonc.2024.1351901
|
|
ISSN:
|
2234-943X
|
|
DDC Classifikation:
|
610 - Medicine and health
|
|
Dokumentart:
|
Article
|
|
Show full item record
|
